Summary of the medical records of the six patients involved. Bold: abnormal results.
|Patient 1||Patient 2||Patient 3||Patient 4||Patient 5||Patient 6|
|Medical history||Heavy active smoking.||Mitochondrial myopathy, pulmonary emphysema||None||Rheumatoid arthritis, under prednisone treatment 5 mg/day||None||None|
|Consumption of infected meat||From the end of January, 2022|
|Date of first symptoms||Mid-February||Mid-February||Mid-February||NA||Mid-February||NA|
|Signs and symptoms||Asthenia, dyspnea, chest pain, low fever||Myalgia, asthenia, eyelid edema, headache, low fever||Myalgia, dizziness, nausea, low fever, dermographism||None||Non-specific stomach aches||None|
|Maximum eosinophil count (G/L) (N < 0.5)||3.00||1.37||1.81||0.33||1.20||0.3|
|Maximum creatine phosphokinase (U/L) (N < 168)||300||98||250||320||222||334|
|Maximum lactate dehydrogenase (U/L) (N < 220)||339||286||239||234||NA||NA|
|Maximum troponin (ng/L) (N < 14)||51||18||NA||NA||NA||NA|
|Status||Confirmed case||Confirmed case||Confirmed case||Suspected case||Suspected case||Suspected case|
|Treatment||Albendazole 15 mg/kg/day, 14 days; prednisone 1 mg/kg/day, 7 days||Albendazole 15 mg/kg/day, 14 days|
|Follow-up||Improvement during treatment, then relapse of the symptoms.||Still no symptoms so far|
|Improvement after the second course of albendazole and prednisone|
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.